Latest News

Three weeks: Four trophies: One BWB!

BWB’s commitment to the next generation of engineering talent has secured national recognition from one of the industry’s most influential organisations – and a remarkable awards double! ACE – the Association for Consultancy and Engineering – held...

Catapult Ventures sells Haemostatix to Ergomed

Catapult Ventures has completed the sale of its stake in Haemostatix Limited (‘Haemostatix’) to Ergomed plc (‘Ergomed’). Ergomed is acquiring 100 per cent of the issued share capital of Haemostatix for an initial consideration of £8.0 million, with...

Yospace wins at Mediatel’s Connected Consumer Awards

Yospace is delighted to have won in the Connected Content Service of the Year category of Mediatel’s prestigious Connected Consumer Awards. The category recognizes innovations such as new advertising models and formats and was awarded to Yospace for its work with Channel 4...

Blueberry Therapeutics raises £3m led by GM&C Life Sciences Fund

Alderley Park, Cheshire, UK - 5th May 2016. Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The investment was led by the GM&C Life Sciences Fund...

Yospace Wins NewBay Media’s Best of Show Award, Presented by TV Technology

Yospace is delighted to have won NewBay Media’s Best of Show Award, presented at the 2016 NAB Show in Las Vegas by TV Technology. The award recognises the importance of Yospace’s Dynamic Ad Insertion platform in enabling live channels to be monetised when viewed...

Catapult exits Food and Drug Analytical Services

Oxford BioTherapeutics Licenses Nerviano Medical Sciences' Drug-Linker Technology to Develop Novel Antibody Drug Conjugates

Oxford BioTherapeutics (OBT), a company developing a range of innovative Antibody Drug Conjugates (ADCs) for the treatment of cancer and Nerviano Medical Sciences (Nerviano), a company of the NMS Group dedicated to the discovery and development of breakthrough treatments for...

Sky Media to use Yospace’s live ad insertion solution for Sky Go

Sky Media has chosen Yospace to provide a dynamic advertisement replacement solution for Sky Go, the leading ‘TV everywhere’ service in Europe. In addition to enabling dynamic ad serving on Sky Go Linear for the first time, Sky is now also able to reproduce the key...

Abzena issues business update – strong second half momentum

Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products, provides the following update. Broadening of service offering … As part of...

GM&C Life Sciences Fund announces first investments

The GM&C Life Sciences Fund has announced that it has concluded its first two investments in February. The Fund, which is managed by Catapult Ventures and targets exciting life science investments in the Greater Manchester and Cheshire regions, has invested in...